Search

All eyes on Twiggy as she fronts new campaign warning us: don’t lose focus of your eye health

Dame Twiggy Lawson fronts a new public awareness campaign focused on eye health, as cases of macular disease increase with our ageing population.

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Orbis marks 100-millionth antibiotic dose in the fight against trachoma in Ethiopia

Orbis and partners mark historic 100-millionth dose of azithromycin antibiotics in the fight to eliminate blinding trachoma in Ethiopia by 2030. This milestone was achieved 20 years after Orbis began leading mass drug administrations.

WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development

In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.

Orbis eye health programme integrated into school curriculum in Nepal

Leading eyecare charity Orbis and Nepal’s National Society of Comprehensive Eye Care (NNJS) have worked together since 2019 to implement a programme called REACH (Refractive Error Among Children) in Eastern Nepal.

Leading North London eye clinic appoints retina expert to treat growing ‘epidemic’ of patients living with myopia

Leading independent eye hospital based in Finchley, My-iClinic, has welcomed Consultant Ophthalmologist, Ms Yvonne Luo, to its growing team of specialists.

Report: National Student Ophthalmology Conference 2023

A report covering the NSOC23 event which took place on 25 March 2023.

LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation

Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...

Global attention was on the importance of children’s eye health during World Sight Day

Over one million pairs of young eyes tested for World Sight Day. IAPB Global Ambassador, HRH Duchess of Edinburgh, reads Specs for Rex on CBeebies Bedtime Story to commemorate World Sight Day. IAPB, in collaboration with the Seva Foundation, releases...

Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board

Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...